DUOC KHOA PHARMACEUTICAL JOINT STOCK COMPANY – Trademark Portfolio

Entity Type: 09

DUOC KHOA PHARMACEUTICAL JOINT STOCK COMPANY holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include DK PHARMA. The owner is based in Ha Noi,.

9 Nguyen Cong Tru Street,

Ha Noi, 10000 , VN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DK PHARMA
DK PHARMA
Registered 2023

Trademark Classifications

DUOC KHOA PHARMACEUTICAL JOINT STOCK COMPANY's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does DUOC KHOA PHARMACEUTICAL JOINT STOCK COMPANY have?

DUOC KHOA PHARMACEUTICAL JOINT STOCK COMPANY has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does DUOC KHOA PHARMACEUTICAL JOINT STOCK COMPANY file in?

DUOC KHOA PHARMACEUTICAL JOINT STOCK COMPANY files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are DUOC KHOA PHARMACEUTICAL JOINT STOCK COMPANY's most well-known trademarks?

DUOC KHOA PHARMACEUTICAL JOINT STOCK COMPANY's registered trademark portfolio includes well-known marks such as DK PHARMA. These are among 1 currently registered trademark in the portfolio.

What is DUOC KHOA PHARMACEUTICAL JOINT STOCK COMPANY's trademark registration success rate?

DUOC KHOA PHARMACEUTICAL JOINT STOCK COMPANY has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.